FK409 ameliorates ischemia-reperfusion injury in heart transplantation following 12-hour cold preservation

Journal of Heart and Lung Transplantation

Volumn 19, Issue 7, 2000, Pages 694-700

  Mohara, Jun ^a   Oshima, Kiyohiro ^a   Tsutsumi, Hirofumi ^a   Takeyoshi, Izumi ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ENDOTHELIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CRYOPRESERVATION; DOG; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME;

ADENOSINE; ALLOPURINOL; ANIMALS; CARDIAC OUTPUT; COLD; DOGS; ENDOTHELIN-1; GLUTATHIONE; HEART TRANSPLANTATION; INFUSIONS, INTRAVENOUS; INSULIN; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE DONORS; NITRO COMPOUNDS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; RECOVERY OF FUNCTION; VENTRICULAR PRESSURE;

EID: 0033898372     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00122-4     Document Type: Article

References (31)

1. Hino M., Iwami M., Okamoto M., et al. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo). 42:1989;1578-1583.
2. Hirasawa Y., Nishio M., Maeda K., Yoshida K., Kita Y. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue. Eur J Pharmacol. 272:1995;39-43.
3. Kita Y., Hirasawa Y., Yoshida K., Maeda K. Antiplatelet activities of FK409, a new spontaneous NO releaser. Br J Pharmacol. 113:1994;385-388.
4. Ohtsuka M., Koibuchi Y., Sakai S., et al. Cardiovascular activity of FK409, a new drug for ischemic heart diseases, on dog in vitro and in vivo preparations. Eur J Pharmacol. 183:(4):1990;1292-1293.
5. Lower R.R., Shumway N.E. Studies on orthotopic homotransplantation of the canine heart. Surg Forum. 11:1960;18-19.
6. Morishita Y. Orthotopic allotransplantation of the preserved canine heart. Acta Med Univ Kagoshima. 16:1974;107-125.
7. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
8. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic Res Comms. 18:1993;195-199.
9. Kubes P., Suzuki M., Granger D.N. Nitric oxide an endogenous modulator of leukocyte adhesion . Proc Natl Acad Sci USA. 88:1991;4651-4655.
10. Prónai L., Ichimori K., Nozaki H., et al. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies. Eur J Biochem. 202:1991;923-930.
11. Yamashita M., Schmid R.A., Ando K., Cooper J.D., Patterson G.A. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg. 62:1996;791-797.
12. Lefer D.J., Nakanishi K., Johnston W.E., Vinten Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 88:1993;2337-2350.
13. Hiramatsu T., Forbess J.M., Miura T., Mayer J.E. Jr. Effect of L-arginine cardioplegia on recovery of neonatal lamb hearts after 2 hours of cold ischemia. Ann Thorac Surg. 60:1995;1187-1192.
14. Hammon J.W. Jr, Vinten Johansen J. Augmentation of microvascular nitric oxide improves myocardial performance following global ischemia. J Card Surg. 10:1995;423-427.
15. Shiraishi M., Hiroyasu S., Nagahama M., et al. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res. 69:1997;429-434.
16. Kato M., Nishino S., Ohno M., et al. New reagents for controlled release of nitric oxide. Structure-stability relationships. Bioorg Med Chem Lett. 6:1996;33-38.
17. Décout J.L., Roy B., Fontecave M., Muller J.C., Williams P.H., Loyaux D. Decomposition of FK409, a new vasodilator identification of nitric oxide as a metabolite . Bioorg Med Chem Lett. 5:1995;973-978.
18. Ohmori H., Dhar D.K., Nakashima Y., Hashimoto M., Masumura S., Nagasue N. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Transplantation. 66:1998;579-585.
19. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
20. Hiramatsu T, Forbess J, Miura T, Roth SJ, Cioffi MA, Mayer JE Jr. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts. Circulation 1995;92(suppl II):II400-4.
21. Nichols A.J., Koster P.F., Ohlstein E.H. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog. Br J Pharmacol. 99:1990;597-601.
22. Mizutani H., Minamoto K., Aoe M., et al. Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in canine lung transplantation model. J Heart Lung Transplant. 17:1998;835-845.
23. Kourembanas S., McQillan L.P., Leung G.K., Faller D.V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 92:1993;99-104.
24. Tsao P.S., Aoki N., Lefer D.J., Johnson G. III, Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 82:1990;1402-1412.
25. Maulik N., Liu X., Subramanian R., Das D.K. Release of endothelin during reperfusion of ischemic myocardium. ET-1 release from reperfused heart. Am J Cardiovasc Pathol. 4:1992;133-144.
26. Velasco C.E., Turner M., Inagami T., et al. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J. 128:1994;441-451.
27. Kourembanas S., Marsden P.A., McQuillan L.P., Faller D.V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 88:1991;1054-1057.
28. Katori M., Tamaki Y., Hui Y., Konoeda Y., Tanaka M., Kawamura A. Beneficial impact of FK409 as donor pretreatment on warm or cold ischemically injured hearts in the rat. Transplant Proc. 30:1998;91-93.
29. Tanahashi Y., Takeyoshi I., Aiba M., Ohwada S., Matsumoto K., Morishita Y. The effect of FK409 on pulmonary ischemia-reperfusion injury in dogs. Transplant Int. 12:1999;402-407.
30. Sunose Y., Takeyoshi I., Ohwada S., et al. The effect of FK409 on ischemia-reperfusion injury in lung transplantation models. J Heart and Lung Transplant. 19:2000;298-309.
31. Schaper J, Mulch J, Winkler B, Schaper W. Ultrastructural, functional, and biochemical criteria for estimation of reversibility of ischemic injury: a study on the effects of global ischemia on the isolated dog heart. J Mol Cell Cardiol 1979;11:521-41.